SULIDAPA MXR (Dapagliflozin (10mg) + Metformin (1000mg))

Sulidapa MXR 10mg/1000mg Extended Release Tablet is a medicinal combination designed for managing type 2 diabetes mellitus. This formulation aids in the regulation of elevated blood sugar levels associated with diabetes, thereby decreasing the risk of severe complications such as kidney damage and cardiovascular issues. It is crucial to take this medication consistently as directed by your healthcare provider, ideally with a meal, to enhance its efficacy and to help in establishing a routine. The dosing regimen will be determined by your doctor, and it is essential not to discontinue use without consulting them first, as stopping the medication abruptly could lead to a spike in blood sugar levels that increases the risk of serious health issues, including blindness and kidney failure. This medication should be part of a comprehensive treatment plan that includes dietary changes, physical activity, and weight management as advised by your healthcare professional. Patients are encouraged to stay well-hydrated to avoid dehydration while using this medication. Some individuals may encounter fungal infections in the genital region; maintaining proper hygiene can mitigate this risk. Before initiating treatment, it is vital to inform your healthcare provider of any pre-existing kidney or liver conditions, urinary tract infections, or if you are using diuretics. Pregnant or nursing individuals should also consult their healthcare provider before starting this medication. Regular monitoring of blood sugar levels is recommended while on this treatment.